Last week, U.S. consumer groups and labour unions petitioned the U.S. Federal Trade Commission to block Novo Holdings, the ...

The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.

The company's financial results should remain strong for a while. Analysts expect earnings per share (EPS) to grow at an ...

Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...

Eli Lilly is just weeks away from launching Mounjaro in the UK, after getting approval from medicines regulator, the MHRA, for a new formulation of the drug as a treatment for diabetes and obesity.

An analysis of the FINEARTS-HF trial, which showed finerenone's benefits in heart failure outcomes, shows no significant ...

More than 80 companies, out of 110 S&P500 companies that reported earnings this week, delivered EPS wins, but they were not ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 23, 2024. REUTERS/Brendan McDermid/File Photo The Nasdaq ended higher on Friday, driven by megacap ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof ...

A 21-year-old woman accused of assault has appeared in court.